Key Segments:
By Product
-
Fixed Medical Oxygen Concentrators
-
Portable Medical Oxygen Concentrators
By Technology
-
Continuous Flow
-
Pulse Flow
By End-Use
-
Home Care
-
Non-Home Care
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Oxygen Concentrator Market is expected to grow at a CAGR of 5.56% from 2026 to 2035.
Increasing incidence of chronic respiratory disorders including COPD and asthma combined with a growing aging population, rising preference for home-based oxygen therapy, and advances in portable concentrator technology is the primary driver of sustained market growth through 2035.
The Fixed Medical Oxygen Concentrators segment dominated the Oxygen Concentrator Market in 2025, accounting for approximately 58.14% of global revenue, owing to its extensive clinical and homecare application for patients requiring long-term continuous oxygen therapy.
The Continuous Flow segment dominated the Oxygen Concentrator Market in 2025 with approximately 57.16% revenue share, driven by its widespread application in intensive care, hospital, and home care settings requiring uninterrupted oxygen delivery.
North America dominated the Oxygen Concentrator Market in 2025, accounting for approximately 39.24% of global market revenue, driven by advanced healthcare infrastructure, strong insurance reimbursement for home oxygen therapy, and high awareness of chronic respiratory disorders.